The findings, published in the Journal of Clinical Investigation, stemmed from previous research by one of the co-authors, Lei Liu at Capital Medical University in Beijing, which found that the prostate drug, terazosin, could block cell death.
This is a companion discussion topic for the original article at https://patient.info/news-and-features/prostate-cancer-drug-could-help-slow-down-parkinsons